4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-22-007774
Options or other derivatives
- Senior VP, Chief Pharma Dev. acquired 12,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2022-02-24 | Grant or award · Call Option | +12,250 | 12,250 | D | ||
Loading xslF345X03/doc4.xml…